Provided by Tiger Trade Technology Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

8.64
+0.35004.22%
Post-market: 8.57-0.0700-0.81%19:44 EDT
Volume:9.39M
Turnover:81.00M
Market Cap:2.24B
PE:-16.31
High:8.87
Open:8.28
Low:8.20
Close:8.29
52wk High:8.87
52wk Low:2.28
Shares:259.67M
Float Shares:103.00M
Volume Ratio:1.36
T/O Rate:9.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5299
EPS(LYR):-0.9059
ROE:-33.05%
ROA:-5.71%
PB:10.96
PE(LYR):-9.54

Loading ...

Top Midday Gainers

MT Newswires Live
·
Aug 21

Why Maravai LifeSciences Holdings (MRVI) Stock Climbed After Its Latest Update

Simply Wall St.
·
Aug 20

Maravai Lifesciences up over 30%, on Pace for Largest Percent Increase in over a Year

Dow Jones
·
Aug 19

Maravai Lifesciences Earnings Call Highlights Margin Rebound

TIPRANKS
·
Aug 18

Maravai LifeSciences Posts Investor Presentation on mRNA, Gene Editing, Cell and Gene Therapy Tools Platform

Reuters
·
Aug 07

Maravai LifeSciences Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Maravai LifeSciences Q2 Revenue Beats Estimates on Strong TriLink Demand

Reuters
·
Aug 07

Maravai Q2 FY26 Net Loss Narrows to $21.6 Million; Revenue Rises 8.5% to $51.4 Million

Reuters
·
Aug 07

Maravai LifeSciences Q2 Adj. EPS $(0.02) Beats $(0.04) Estimate, Sales $51.442M Beat $48.682M Estimate

Benzinga Earnings
·
Aug 07

Maravai LifeSciences Q2 Revenue USD 51.4 Million Vs. IBES Estimate USD 48.7 Million

Reuters
·
Aug 07

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 07

Maravai LifeSciences Holdings Inc Expected to Post a Loss of 4 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Earning Preview: Maravai LifeSciences Holdings, Inc. this quarter’s revenue is expected to increase by 2.78%, and institutional views are bullish

Earnings Agent
·
Jul 31

Maravai Lifesciences Schedules Quarterly Earnings Call

Reuters
·
Jul 23

Maravai Unit Trilink Wins China Patent for Cleancap Mrna Capping Technology

Reuters
·
Jul 21

TriLink, Maravai LifeSciences unit, opens GMP enzyme manufacturing facility in Florida

Reuters
·
Jun 16

Maravai LifeSciences General Counsel Kurt Oreshack disposes of shares worth $253,000

Reuters
·
Jun 11

Maravai Lifesciences announces refinancing of credit agreement

TIPRANKS
·
Jun 03

Maravai LifeSciences refinances credit agreement with USD 150 million term loan, extends maturity to 2032

Reuters
·
Jun 03

Maravai LifeSciences - Announces New Credit Agreement With $150 Mln Term Loan and $30 Mln Revolving Facility

THOMSON REUTERS
·
Jun 03